BFRI 1 (-3.85%)
US09077D1000Drug ManufacturersDrug Manufacturers - Specialty & Generic

Biofrontera (BFRI) Stock Highlights

1 | -3.85%
2024-06-06 06:05:02
Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

Statistics

Range Today
1 1.07
Volume Today 23.4K
Range 1 Year
0.61 13.42
Volume 1 Year 57.75M
Range 3 Year
0.61 292.6
Volume 3 Year 124.99M
Range 10 Year
0.61 292.6
Volume 10 Year 124.99M

Highlights

Market Capitalization 5.24M (micro)
Floating Shares 2.62M
Current Price 1
Price To Earnings -0.1
Price To Revenue 0.26
Earnings Per Share -10.3
Payout Ratio 0%

Performance

Latest -3.85%
1 Month -43.82%
3 Months +11.11%
6 Months -73.19%
1 Year -89.78%
3 Years -98.78%
5 Years -98.78%
10 Years -98.78%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.